{"version":"1.0","type":"card","id":"dac63e27-e944-4e36-9fb4-70ae2deca440","url":"https://stacklist.com/card/dac63e27-e944-4e36-9fb4-70ae2deca440","title":"Vitadio - pioneering prescription digital therapeutics","source_url":"https://vitad.io/","note":"The first digital therapy for type 2 diabetes covered by all statutory health insurers in Germany.","image":{"url":"https://ucarecdn.com/e6b525ac-ae95-4c87-9925-d82629d36077/","alt":"Vitadio - pioneering prescription digital therapeutics","width":1200,"height":630},"stack":{"id":"419b3570-b483-40cf-bafc-961bd3938eab","title":"Healthcare AI & Digital Health Solutions","url":"https://stacklist.com/c/wellness/stack/jAe5oQmthBd1FjR1dmF2"},"created_at":"2025-05-06T22:20:30.485Z","updated_at":null,"aco":{"summary":"Vitad.io is a website for Vitadio, a company that develops and provides digital therapeutics for type 2 diabetes and prediabetes. Their platform uses AI-driven lifestyle modification to reverse insulin resistance. They claim to be the first digital therapy for type 2 diabetes covered by statutory health insurers in Germany and have a robust platform with personalized therapy, AI-driven feedback, and proactive human support. They also highlight clinical studies that support their effectiveness, showing patients achieved a higher HbA1c level and weight reduction than standard care. Vitadio is currently available in Czech, Italian, and German languages. \n","tags":[],"key_entities":[],"classification":null,"language":null,"confidence":null,"provenance":null,"token_counts":{"approximate":176},"content_hash":null,"acp_version":"0.2","body_available":false,"body_tokens":0,"visibility":"public","agent_accessible":true,"status":"final"},"_links":{"self":"/api/public/card/dac63e27-e944-4e36-9fb4-70ae2deca440.json","html":"https://stacklist.com/card/dac63e27-e944-4e36-9fb4-70ae2deca440","md":"/api/public/card/dac63e27-e944-4e36-9fb4-70ae2deca440.md","stack_json":"/api/public/stack/419b3570-b483-40cf-bafc-961bd3938eab.json"}}